- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x K: POTASSIUM ION(Non-covalent)
K.3: 6 residues within 4Å:- Chain A: V.298, D.300, F.303, G.337, P.341
- Ligands: ADP.1
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:V.298, A:D.300, A:F.303
K.8: 6 residues within 4Å:- Chain B: V.298, D.300, F.303, G.337, P.341
- Ligands: ADP.6
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:V.298, B:D.300, B:F.303
- 2 x 01: (3M)-6-fluoro-3-(2,4,5-trifluoro-3-methoxyphenyl)-1-benzothiophene-2-carboxylic acid
01.4: 15 residues within 4Å:- Chain A: L.68, I.72, R.75, Y.99, A.102, L.106, V.125, L.128, L.129, H.132, T.163, R.167, I.170, R.171, A.174
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:L.68, A:I.72, A:L.106, A:L.128, A:L.128, A:I.170
- Hydrogen bonds: A:Y.99
- Salt bridges: A:H.132, A:R.167, A:R.171
- pi-Stacking: A:Y.99
- pi-Cation interactions: A:H.132
- Halogen bonds: A:I.72, A:Y.99
01.9: 15 residues within 4Å:- Chain B: L.68, I.72, R.75, Y.99, A.102, L.106, V.125, L.128, L.129, H.132, T.163, R.167, I.170, R.171, A.174
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:L.68, B:I.72, B:L.106, B:L.128, B:L.128, B:I.170
- Salt bridges: B:H.132, B:R.167, B:R.171
- pi-Stacking: B:Y.99
- pi-Cation interactions: B:H.132
- Halogen bonds: B:I.72, B:Y.99
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.5: 7 residues within 4Å:- Chain A: E.245, F.336, G.337, F.338, G.339
- Ligands: ADP.1, MG.2
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:Y.241, A:E.245, A:E.245, A:E.245, A:F.336, A:G.337, A:F.338, A:G.339
- Water bridges: A:R.252
- Salt bridges: A:K.248
PO4.10: 7 residues within 4Å:- Chain B: E.245, F.336, G.337, F.338, G.339
- Ligands: ADP.6, MG.7
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:E.245, B:E.245, B:F.336, B:G.337, B:F.338, B:G.339
- Water bridges: B:N.249, B:R.252
- Salt bridges: B:K.248
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Filipski, K.J. et al., Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948. J.Med.Chem. (2024)
- Release Date
- 2024-11-27
- Peptides
- Branched-chain alpha-ketoacid dehydrogenase kinase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x K: POTASSIUM ION(Non-covalent)
- 2 x 01: (3M)-6-fluoro-3-(2,4,5-trifluoro-3-methoxyphenyl)-1-benzothiophene-2-carboxylic acid
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Filipski, K.J. et al., Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948. J.Med.Chem. (2024)
- Release Date
- 2024-11-27
- Peptides
- Branched-chain alpha-ketoacid dehydrogenase kinase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A